Skip to main content
Premium Trial:

Request an Annual Quote

EMBL-DKFZ Chemical Genomics Facility Partners with Tripos on Cheminformatics

NEW YORK, July 20 (GenomeWeb News) - A chemical genomics facility managed by the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) will use informatics software and services from Tripos to help analyze small-molecule screening data, the company said today.

 

The screening facility, based in Heidelberg, Germany, was launched in March and employs six full-time researchers.

 

Under the terms of the agreement, Tripos Discovery Research, Tripos' UK-based chemistry division, will provide the facility with a chemistry database and other chemistry processes to assist with hit finding, hit follow-up, and chemical optimization of candidate molecules.

 

Financial terms of the collaboration were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more